Patent US5055460A successfully refreshed from Google Patents.
US5055460A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for weight loss
Assignee: AMERICAN PHYTOTHERAPY RESEARCH LABORATORY
•
Filing: 1990-04-26
•
Granted: 1991-10-08
•
Expires: 2010-04-26
Abstract
Abstract A method for producing or maintaining weight loss by administering to a human a composition containing an effective amount of each of caffine, aspirin and ephedrine. The pharmaceutical composition can be administered concurrently with caloric restriction or in the absence of caloric restriction, for the purpose of reducing weight or maintaining body weight.
Inventors
- 👤 Mitchell Friedlander
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 20:24
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/60; A61K31/618; A61K31/621
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
31 words
A method for producing weight loss in a human in need thereof, comprising administering thereto an effective amount of a composition comprising aspirin, caffeine and ephedrine or pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim
31 words
A method for producing weight loss in a human in need thereof, comprising administering thereto an effective amount of a composition comprising aspirin, caffeine and ephedrine or pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
21 words
The method of claim 1, wherein about 30-2500 mg/day aspirin, about 10-500 mg/day caffeine and about 25-350 mg/day ephedrine are administered.
Claim 4
Dependent Claim
21 words
The method of claim 1, wherein about 200-1000 mg/day aspirin, about 30-200 mg/day caffeine and about 50-100 mg/day ephedrine are administered.
Claim 5
Dependent Claim
21 words
The method of claim 1, wherein about 300 mg/day aspirin, about 120 mg/day caffeine and about 150 mg/day ephedrine are administered.
Claim 6
Dependent Claim
25 words
The method of claim 1, wherein the amount of aspirin, caffeine and ephedrine administered is in a relative ratio of about 2.0:1.0:0.5 to about 3.5:1.0:2.0.
Claim 7
Dependent Claim
11 words
The method of claim 5, wherein said ratio is about 2.75:1.0:1.25.
Claim 8
Dependent Claim
11 words
The method of claim 1, wherein said composition is administered orally.
Claim 9
Dependent Claim
13 words
The method of claim 1, wherein said composition is in unit dose form.
Claim 10
Dependent Claim
21 words
The method of claim 8, wherein said unit dose comprises about 30-2500 mg aspirin, 10-500 mg caffeine and 25-350 mg ephedrine.
Claim 11
Dependent Claim
21 words
The method of claim 8, wherein said unit dose comprises about 200-1000 mg aspirin, 30-200 mg caffeine and 50-100 mg ephedrine.
Claim 12
Dependent Claim
21 words
The method of claim 8, wherein said unit dose comprises about 300 mg aspirin, 120 mg caffeine and 150 mg ephedrine.
Claim 13
Dependent Claim
17 words
The method of claim 1, wherein said composition is administered with a pharmaceutically acceptable carrier or excipient.
Claim 14
Dependent Claim
12 words
The method of claim 1, wherein said human is overweight or obese.
Claim 15
Dependent Claim
12 words
The method of claim 1, wherein said human is low energy adapted.
Claim 16
Independent Claim
15 words
The method of clam 1, further comprising calorically restricting said human during said administering step.
Claim 17
Independent Claim
15 words
The method of clam 1, further comprising calorically restricting said human during said administering step.
Claim 18
Independent Claim
37 words
A method for producing weight loss in a calorically restricted human in need thereof, comprising administering to the human a composition comprising an effective amount of each of aspirin, caffeine and ephedrine or pharmaceutically acceptable salts thereof.
Claim 19
Independent Claim
37 words
A method for producing weight loss in a calorically restricted human in need thereof, comprising administering to the human a composition comprising an effective amount of each of aspirin, caffeine and ephedrine or pharmaceutically acceptable salts thereof.
Claim 20
Dependent Claim
21 words
The method of claim 16, wherein about 30-2500 mg/day aspirin, about 10-500 mg/day caffeine and about 25-350 mg/day ephedrine are administered.
Claim 21
Dependent Claim
21 words
The method of claim 16, wherein about 200-1000 mg/day aspirin, about 30-200 mg/day caffeine and about 50-100 mg/day ephedrine are administered.
Claim 22
Dependent Claim
21 words
The method of claim 16, wherein about 300 mg/day aspirin, about 120 mg/day caffeine and about 150 mg/day ephedrine are administered.
Claim 23
Dependent Claim
25 words
The method of claim 16, wherein the amount of aspirin, caffeine and ephedrine administered is in a relative ratio of about 2.0:1.0:0.5 to about 3.5:1.0:2.0.
Claim 24
Dependent Claim
11 words
The method of claim 16, wherein said ratio is about 2.75:1.0:1.25.
Claim 25
Dependent Claim
11 words
The method of claim 16, wherein said composition is administered orally.
Claim 26
Dependent Claim
13 words
The method of claim 16, wherein said composition is in unit dose form.
Claim 27
Dependent Claim
21 words
The method of claim 16, wherein said unit dose comprises about 30-2500 mg aspirin, 10-500 mg caffeine and 25-350 mg ephedrine.
Claim 28
Dependent Claim
21 words
The method of claim 16, wherein said unit dose comprises about 200-1000 mg aspirin, 30-200 mg caffeine and 50-100 mg ephedrine.
Claim 29
Dependent Claim
21 words
The method of claim 16, wherein said unit dose comprises about 300 mg aspirin, 120 mg caffeine and 150 mg ephedrine.
Claim 30
Dependent Claim
17 words
The method of claim 16, wherein said composition is administered with a pharmaceutically acceptable carrier or excipient.
Claim 31
Dependent Claim
12 words
The method of claim 16, wherein said human is low energy adapted.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-10-07 | 1995-04-08 | 1995-10-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-10-07 | 1999-04-08 | 1999-10-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-10-07 | 2003-04-08 | 2003-10-08 | $7700.00 | Window Closed / Lapsed |